Skip to content
  • ABOUT US
  • HISTORY
  • BLOG
  • SCIENTIFIC AREA
  • GALLERY
  • CAREERS
  • SUPPORT
  • CONTACT US
  • DOWNLOADS
  • LOGIN
  • SERVICES
  • CLINICAL CHEMISTRY
  • FIT
    • ASSAYS
      • FOB Gold® line
        • FOB Gold®
      • CALiaGold® line
    • INSTRUMENTS
      • SENTiFIT® 270
      • SENTiFOB®
      • SENTiFIT®800
  • MOLECULAR DIAGNOSTICS
    • ASSAYS
      • RESPIRATORY
        • COVID-19 Molecular Assays
        • COVID-19 Serological Assays
      • VIROLOGY
        • STAT-NAT virology kits
      • HEALTHCAREAssociated Infections
        • STAT-NAT® VRE
      • PARASITOLOGY
        • STAT-NAT®Leishmania spp.
      • Universal DNA & RNA MIX
    • INSTRUMENTS
      • SENTiNAT®200
  • CHROMATOGRAPHY

BLOG

Home / BLOG

Sentinel promotes experts discussion on Covid-19 testing

29/05/202129/05/2021
Sentinel promotes experts discussion on Covid-19 testing

With the effort to support scientific highly valuable discussion around Covid-19 topics, Sentinel Diagnostics is proud to organize a round table discussion on June, 10th: “LOOKING BEYOND THE COVID-19 PANDEMIC: LESSONS LEARNED AND FUTURE PERSPECTIVE ON DIAGNOSIS AND EPIDEMIOLOGICAL STUDIES” Our guests, dr Fulvio Ferrara, Head of  Department of Laboratory Medicine, Pathology and Molecular Genetics and […]

READ MORE "Sentinel promotes experts discussion on Covid-19 testing"




Sentinel Diagnostics Iniziative to support cancer research

07/05/202112/05/2021
Sentinel Diagnostics Iniziative to support cancer research

On the occasion of Mother’s Day, the Sentinel Diagnostics Board of Directors dedicates a wish to all our mothers and women employees who work every day to ensure that our customers have reliable diagnoses and thanks them with a special gesture. In fact, it is with pleasure that Sentinel Diagnostics gives each of our employees […]

READ MORE "Sentinel Diagnostics Iniziative to support cancer research"




Sentinel Diagnostics announces the launch of the new quantitative serological kits COVID-19

04/05/202104/05/2021
Sentinel Diagnostics announces the launch of the new quantitative serological kits COVID-19

As Sentinal Diagnostics, we are committed to support healthcare professionals to fight COVID-19 pandemic, thus we have developed two new kits to detect the total antibodies (IgA, IgG and IgM) against Spike and Nucleocapside proteins of SARS-CoV-2. COVID-19 Anti-S1 Total Ab and COVID-19 Anti-NC Total Ab assays are In Vitro Diagnostic tests, for quantitative and […]

READ MORE "Sentinel Diagnostics announces the launch of the new quantitative serological kits COVID-19"




UK, South African and Brazilian variants SARS-CoV-2 mutations don’t affects the targets of Sentinel Diagnostics’ kits

08/02/202108/02/2021
UK, South African and Brazilian variants SARS-CoV-2 mutations don’t affects the targets of Sentinel Diagnostics’ kits

As Sentinel Diagnostics we are constantly working from the beginning of the COVID-19 pandemia providing high quality test for SARS-CoV-2 detection. Recently new virus variants appeared, such as the UK variant (B.1.1.7), the South African variant (B.1.351), and the Brazilian variant (P.1). This raised concerns regarding their potential increased virulence and resistance to neutralizing Ab. […]

READ MORE "UK, South African and Brazilian variants SARS-CoV-2 mutations don’t affects the targets of Sentinel Diagnostics’ kits"




Forbes Italia applauds Sentinel Diagnostics as champion of the Italian business

25/01/202125/01/2021
Forbes Italia applauds Sentinel Diagnostics as champion of the Italian business

Sentinel Diagnostics is part of the successful companies celebrated by the magazine Forbes Italia, regarding the second edition of the Imprese Vincenti Award (Banca Intesa Sanpaolo). Almost 4.000 companies have applied and, after a careful selection, the committee has chosen the 144 winning companies, which are the best expression of the Italian economic fabric, with revenues […]

READ MORE "Forbes Italia applauds Sentinel Diagnostics as champion of the Italian business"




STAT-NAT®COVID-19 MULTI, the value of simplicity

04/08/202005/08/2020
STAT-NAT®COVID-19 MULTI, the value of simplicity

STAT-NAT®COVID-19 MULTI is the new configuration of ready-to-use lyo Real-Time PCR mix for the detection of novel coronavirus disease. The world is experiencing a fast increase of SARS-CoV-2 testing demand and needs a more rapid and simplified testing capacity. STAT-NAT®COVID 19 MULTI is the answer for these new needs. The all in one tube approach […]

READ MORE "STAT-NAT®COVID-19 MULTI, the value of simplicity"




Another weapon against COVID-19

25/06/202003/05/2021
Another weapon against COVID-19

STAT-NAT® RNA Mix is the universal platform for nucleic acids amplification techniques (RT-PCR, Real Time RT-PCR) on RNA samples extracted from any biological material. It is a universal RNA Master Mix, that can be used for the extraction and the amplification of viral RNA from human samples. The kit is made with Sentinel’s STAT-NAT® patented […]

READ MORE "Another weapon against COVID-19"




The new consensus-based recommendations from EAS and EFLM are now available.

21/05/202021/05/2020
The new consensus-based recommendations from EAS and EFLM are now available.

Based on the 2019 ESC/EAS Guidelines for the management of dyslipidaemias, the new consensus-based recommendations from EAS and EFLM are now available. The 2019 ESC/EAS Guidelines recommend the Lp(a) analysis for the population over 40-years-old, in order to identify individuals with a high risk to develop atherosclerotic cardiovascular disease. Clinicians claim that a one-off measurement […]

READ MORE "The new consensus-based recommendations from EAS and EFLM are now available."




Our CTO NAT Maurizio Gramegna is one of the Corporate Members of the IFCC Task Force on COVID-19

16/05/202021/05/2020
Our CTO NAT Maurizio Gramegna is one of the Corporate Members of the IFCC Task Force on COVID-19

  The International Federation of Clinical Chemistry and Laboratory Medicine IFCC has established a Task Force on COVID-19, in order to face the Public Health Emergency. Our CTO NAT Maurizio Gramegna has been selected by IFCC to be one of the Corporate Members of the Task Force on COVID-19, thanks to his long-lasting experience in […]

READ MORE "Our CTO NAT Maurizio Gramegna is one of the Corporate Members of the IFCC Task Force on COVID-19"




Our FOB Gold® system is the perfect partner for an efficient screening program

01/04/202006/04/2020
Our FOB Gold® system is the perfect partner for an efficient screening program

As every year, the Dutch RIVM publishes the report “Monitoring and Evaluation of the Colorectal Cancer Screening Programme”, regarding the CRC Screening Program in the Netherlands, with which the Institute proudly underlines the successful results obtained. This outcome, regards all aspects of the procedure, from the enrollment of citizens, to the intake of samples, to […]

READ MORE "Our FOB Gold® system is the perfect partner for an efficient screening program"




Posts navigation
< 1 2 3 4 5 … 11 >


SENTINEL CH. SpA
Via Robert Koch, 2 - 20152 Milano - Italy
Phone +39 02.36.217.1 - Fax 02.36.217.464 - Email: sentinel@sentinel.it
REA: MI-1139796 - P.I.: 07118040158 - Cap.Soc. € 14.000.000,00 i.v.
ISO 9001:2015 - ISO 13485:2016 & EN ISO 13485:2016
ISO 13485:2016 MDSAP (Australia, Brazil, Canada, USA and Japan)
ISO 45001:2018 - ISO 14001:2015
IFCC Corporate MEMBER - IRMM Validated SUPPLIER
Copyright® 2009-2025 SENTINEL. All rights reserved.
PRODUCT LINES
  • LABORATORY
  • MOLECULAR DIAGNOSTICS line
  • FIT line
THE WORLD OF SENTINEL
  • ABOUT US
  • HISTORY
  • BLOG
  • SCIENTIFIC AREA
  • DOWNLOADS
  • LOGIN
  • PRIVACY POLICIES
  • TRANSPARENCY FORM
FOLLOW US
Sentinel LinkedIn
Sentinel Instagram
Sentinel YouTube
LANGUAGE
  • EN
  • IT

SENTINEL IS A CERTIFIED COMPANY ISO 9001:2015 – ISO 13485:2016 & EN ISO 13485:2016 – ISO 13485:2016 MDSAP (Australia, Brazil, Canada, USA and Japan) – ISO 45001:2018 – ISO 14001:2015 IFCC Corporate MEMBER – IRMM Validated SUPPLIER
Attention

The site you are visiting contains advertising material relating to our products.
In accordance with the current legislation, we inform you that the advertising material published on this site is exclusively intended for specialized healthcare personnel.